Big relief to heart patients: Stent prices to be fixed in 10-15 days, says government

By: |
New Delhi | Published: January 18, 2017 5:04:31 PM

With an aim of providing relief to heart patients, the government today said it will fix prices of stents in the next 10-15 days.

Last year in July, the Ministry of Health had included stents in the National List of Essential Medicines. (Reuters)Last year in July, the Ministry of Health had included stents in the National List of Essential Medicines. (Reuters)

With an aim of providing relief to heart patients, the government today said it will fix prices of stents in the next 10-15 days. Chemicals and Fertilzers Minister Ananth Kumar said that drug price regulator National Pharmaceuticals Pricing Authority (NPPA) has already been asked to take up the matter. “We have asked NPPA to fix prices of stents. This issue is pending for long. The price will be fixed in the next 10 to 15 days. This will give huge relief to patients,” Kumar said here.

He was speaking on the sidelines of signing of an MoU between Bureau of Pharma PSUs of India (BPPI) and National Yuva Co-operative Society for opening of 1,000 Jan Aushadhi drug stores across India.

The NPPA has already asked manufacturers and marketers of the medical device to disclose detailed pricing data and information by the end of this month.

You may also like to watch:

It has also called for a meeting with the stakeholders to discuss the issue on January 24.

Last year in July, the Ministry of Health had included stents in the National List of Essential Medicines, whereby the device came under purview of price control of the government.

The step was taken as it was felt that the margin for hospitals in terms of MRP of the stents was too high. The government based its decision on a sub-committee report that recommended putting all types of stents into the list.

Industry players had, however, criticised the move. Medical devices sector body AdvaMed and industry chamber CII said the step would not help improve access to medical devices for patients as it will not impact the overall procedure cost.

When asked if the role of NPPA would be changed as was speculated, Kumar replied in the negative and said its mandate is to regulate drug prices and would continue to do so.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition
FinancialExpress_1x1_Imp_Desktop